Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Circa Pharmaceuticals

This article was originally published in The Tan Sheet

Executive Summary

Receives FDA approval for its 4 mg polacrilex nicotine gum (ANDA 74-707) March 19. The Watson Pharmaceutical subsidiary also receives approval for a 2 mg version of the product (ANDA 74-507) March 15. SmithKline Beecham's Nicorette smoking cessation gum, the reference product, lost its Waxman/Hatch exclusivity Feb. 9, but launched a mint-flavored gum in January to stave off the private label competition ("The Tan Sheet" Jan. 18, p. 4). The Circa product is the first private label nicotine gum to be approved by the agency. Novopharm, Gumtech and Perrigo also are expected to market nicotine replacement gum in the future

You may also be interested in...



SmithKline Seeks Injunction Against Watson Nicotine Gum Labeling

SmithKline Beecham Consumer Healthcare alleges copyright infringement of the company's Nicorette smoking cessation gum in a lawsuit filed against Watson Pharmaceuticals and its subsidiaries, Watson Laboratories and Circa Pharmaceuticals, Aug. 26.

SmithKline Seeks Injunction Against Watson Nicotine Gum Labeling

SmithKline Beecham Consumer Healthcare alleges copyright infringement of the company's Nicorette smoking cessation gum in a lawsuit filed against Watson Pharmaceuticals and its subsidiaries, Watson Laboratories and Circa Pharmaceuticals, Aug. 26.

SmithKline Seeks Injunction Against Watson Nicotine Gum Labeling

SmithKline Beecham Consumer Healthcare alleges copyright infringement of the company's Nicorette smoking cessation gum in a lawsuit filed against Watson Pharmaceuticals and its subsidiaries, Watson Laboratories and Circa Pharmaceuticals, Aug. 26.

Related Content

Topics

UsernamePublicRestriction

Register

PS089550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel